11/10/2022 4:11:12 PM
AgeX Therapeutics Q3 Loss/share $0.06 Vs. Loss $0.05 Year Ago
8/12/2022 4:12:12 PM
AgeX Therapeutics Q2 Loss/share $0.07, Same As Last Year
5/13/2022 4:10:16 PM
AgeX Therapeutics Q1 Loss/share $0.07 Vs. Loss $0.06 Year Ago
12/14/2021 8:36:44 AM
AgeX To Collaborate With University Of California, Irvine, On Research Program On Certain Brain Disorders
11/30/2021 8:34:31 AM
AgeX Therapeutics' Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed With IMS001
11/12/2021 4:16:56 PM
AgeX Therapeutics Q3 Loss/share $0.05 Vs. Loss $0.07 Year Ago
8/13/2021 4:14:54 PM
AgeX Therapeutics Q2 Loss/share $0.07, Same As Last Year
5/17/2021 4:08:12 PM
AgeX Therapeutics Q1 Loss/share $0.06 Vs. Loss $0.08 Year Ago
3/12/2021 8:07:08 AM
AgeX Therapeutics Announces Online Publication Of Data Relating To Regeneration, Aging, And Cancer In BioRxiv
3/10/2021 8:05:05 AM
AgeX Therapeutics To Partner With The Ohio State University